Stay updated with breaking news from Nasdaq Bcab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 4,450,000 shares, an increase of 8.0% from the November 15th total of 4,120,000 shares. Based on an average daily trading volume, of 408,600 shares, the days-to-cover ratio […]
JMP Securities reiterated their market outperform rating on shares of BioAtla (NASDAQ:BCAB – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. JMP Securities currently has a $12.00 price target on the stock. A number of other equities research analysts have also recently commented on BCAB. JPMorgan Chase & Co. […]
BioAtla (NASDAQ:BCAB – Get Free Report) had its price objective lowered by stock analysts at HC Wainwright from $17.00 to $10.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 468.18% […]
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among […]
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price […]